drugset / Trial / NCT02703649

Administration of Single High Dose Letrozole for Ovulation Induction

NCT02703649

Phase 4 Completed 36 enrolled Mount Sinai Hospital, Canada
RandomizedParallel-groupOpen-labelTreatment

Summary

Letrozole is considered an established treatment for ovulation induction.The most common protocol is daily dose of 2.5-7.5 mg starting day 3-5 of the cycle for 5 days.Another described protocol is single high dose 20mg Letrozole given on day 3 of the cycle. Our aim is to compare the single high dose Letrozole protocol to daily low dose protocol.

Timeline

Start
2016-03
Primary completion
2020-07-31
Completion
2020-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Letrozole Other / unclassified 2.5 mg
Subject Letrozole Other / unclassified 20 mg

Indications